Stevens-Johnson Syndrome/Toxic Epidural Necrolysis 2017: Building Multidisciplinary Networks to Drive Science and Translation
史蒂文斯-约翰逊综合症/中毒性硬膜外坏死松解术 2017:建立多学科网络以推动科学和翻译
基本信息
- 批准号:9261224
- 负责人:
- 金额:$ 4.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAddressAmericanApplications GrantsAreaBasic ScienceBiologyBurn injuryCarbamazepineClinicalClinical PharmacologyCollaborationsCritical CareCutaneousDermatologicDermatologistDermatologyDisciplineDiseaseDrug usageEducationEducational workshopEpidemiologyFloridaFoundationsFutureGeneticGoalsHLA-B AntigensHealthHumanImmunologicsImmunologistImmunologyIncidenceIndividualInformaticsInstitutesInternationalInternetLifeManuscriptsMediatingMentorsMentorshipMinorityMissionMorbidity - disease rateNational Human Genome Research InstituteNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOperative Surgical ProceduresOphthalmologistOphthalmologyOutcomePatient CarePatient-Focused OutcomesPatientsPeer ReviewPharmaceutical PreparationsPopulationPreventionPublicationsPublishing Peer ReviewsRare DiseasesReactionRecruitment ActivityResearchResearch PersonnelResearch PriorityRiskRisk FactorsScienceScientistSkinSpecialistStevens-Johnson SyndromeToxic Epidermal NecrolysisTranslationsUnited StatesUnited States National Institutes of HealthWomanWorkcareercatalystclinical careexperienceimprovedinterdisciplinary approachmeetingsmembermortalitymultidisciplinarypatient advocacy grouppostersprogramsscreeningskillssoutheast Asiansuccesssymposium
项目摘要
Project Summary
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) an immunologically-mediated disease that is usually
drug-induced, is rare (estimated incidence 1-3/1,000,000) but has a high collective burden. It is the severest of
cutaneous adverse drugs reactions, often with >30% mortality and significant short and long-term morbidity.
Advancement in SJS/TEN research, prevention and clinical care within the United States and internationally requires
considerable coordination of multiple disciplines such as critical care, surgery, dermatology, ophthalmology,clinical
pharmacology, epidemiology, regulatory science, informatics, immunology, genetics, skin biology and other areas of
basic science. Significant progress was achieved through a two-day workshop organized by the NIH and led by the NHGRI
in collaboration with the FDA in March 2015 which involved 30 established SJS/TEN researchers to set priorities. There is
currently no ongoing contingency group or conference dedicated to SJS/TEN that would allow a multidisciplinary group
of scientists and clinicians to engage at a single meeting. This proposal seeks support for “Stevens-Johnson
Syndrome/Toxic Epidermal Necrolysis 2017: Building Multidisciplinary Networks to Drive Science & Translation” to
address this unmet need. The meeting will take place March 2, 2017 immediately preceding the American Academy of
Dermatology meeting (March 3-6, 2017) in Orlando, Florida. The program will attract approximately 200 attendees and
will encourage new investigators, trainees, women and minorities across multiple scientific and clinical disciplines,
patients and patient advocacy groups. The one-day program will include presentations and involvement from more
than 20 domestic and international experts both within the area of SJS/TEN or in scientific disciplines that have much to
contribute to the advancement of SJS/TEN. The program will include a variety of presentation formats including keynote
presentations, round table discussions and a poster session. An organizing committee has been assembled that has
outstanding national and international representation and includes women, minorities, new investigators, a trainee and
an SJS foundation member. This meeting will serve to 1) Create networks; 2) Prioritize research goals and unanswered
questions; 3) Provide mentorship for new investigators and trainees; 4) Assemble key researchers for presentation of
cutting edge research; and 5) Address potential barriers to short and long-term progress in SJS/TEN research. It is
anticipated that an important outcome of this meeting will be the creation of a synergistic global network of researchers
that will have a durable and productive collaborative relationship. The proceedings of this meeting will be disseminated
through web-recording and a peer-reviewed publication. Consistent with the mission of the NIAMS and NIH this
meeting will successfully assemble key researchers established or doing work of relevance to this severe life-threatening
cutaneous adverse drug reaction for dissemination, education, translation and fuel significant progress in defining
causes, treatment and prevention of SJS/TEN that will significantly advance human health.
项目概要
史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症 (SJS/TEN) 一种免疫介导的疾病,通常是
药物引起的,很少见(估计发病率为 1-3/1,000,000),但集体负担很高,这是最严重的。
皮肤药物不良反应,死亡率通常>30%,且短期和长期发病率显着。
美国和国际上 SJS/TEN 研究、预防和临床护理的进步需要
重症监护、外科、皮肤科、眼科、临床等多学科的高度协调
药理学、流行病学、监管科学、信息学、免疫学、遗传学、皮肤生物学等领域
NIH 组织、NHGRI 领导的为期两天的研讨会取得了重大进展。
2015 年 3 月与 FDA 合作,由 30 名 SJS/TEN 研究人员参与确定优先事项。
目前还没有专门针对 SJS/TEN 的持续应急小组或会议来允许多学科小组
该提案寻求“史蒂文斯-约翰逊”的支持。
综合征/中毒性表皮坏死松解症 2017:建立多学科网络以推动科学与翻译”
会议将于 2017 年 3 月 2 日在美国科学院会议之前举行。
皮肤病学会议(2017 年 3 月 3 日至 6 日)在佛罗里达州奥兰多举行。该计划将吸引约 200 名与会者。
将鼓励跨多个科学和临床学科的新研究人员、受训人员、妇女和少数族裔,
为期一天的计划将包括更多患者的演讲和参与。
超过 20 位国内外 SJS/TEN 领域或科学学科领域的专家
为 SJS/TEN 的进步做出贡献 该计划将包括各种演示形式,包括主题演讲。
演讲、圆桌讨论和海报会议已经成立。
杰出的国家和国际代表性,包括妇女、少数族裔、新调查员、实习生和
SJS 基金会成员。这次会议将有助于 1) 创建网络 2) 确定研究目标和未解决问题的优先顺序;
问题; 3) 为新研究者和受训者提供指导; 4) 召集关键研究人员进行演示;
前沿研究;以及 5) 解决 SJS/TEN 研究短期和长期进展的潜在障碍。
预计本次会议的一个重要成果将是建立一个协同的全球研究人员网络
将传播本次会议的记录。
通过网络记录和同行评审出版物,这与 NIAMS 和 NIH 的使命一致。
会议将成功聚集已建立或正在从事与这一严重威胁生命的相关工作的主要研究人员
皮肤药物不良反应的传播、教育、翻译并推动在定义方面取得重大进展
SJS/TEN 的病因、治疗和预防将显着促进人类健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Phillips其他文献
Elizabeth Phillips的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Phillips', 18)}}的其他基金
Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) 2023
史蒂文斯约翰逊综合症/中毒性表皮坏死松解症 (SJS/TEN) 2023
- 批准号:
10682795 - 财政年份:2023
- 资助金额:
$ 4.3万 - 项目类别:
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
NATIENS:一项 III 期随机双盲研究,以确定史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的机制和最佳治疗
- 批准号:
10217036 - 财政年份:2020
- 资助金额:
$ 4.3万 - 项目类别:
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
NATIENS:一项 III 期随机双盲研究,以确定史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的机制和最佳治疗
- 批准号:
10402818 - 财政年份:2020
- 资助金额:
$ 4.3万 - 项目类别:
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
NATIENS:一项 III 期随机双盲研究,以确定史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的机制和最佳治疗
- 批准号:
10612063 - 财政年份:2020
- 资助金额:
$ 4.3万 - 项目类别:
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
幸存者中药物引起的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关的遗传风险和长期结果
- 批准号:
10214660 - 财政年份:2019
- 资助金额:
$ 4.3万 - 项目类别:
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
幸存者中药物引起的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关的遗传风险和长期结果
- 批准号:
10441271 - 财政年份:2019
- 资助金额:
$ 4.3万 - 项目类别:
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
幸存者中药物引起的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症相关的遗传风险和长期结果
- 批准号:
10018069 - 财政年份:2019
- 资助金额:
$ 4.3万 - 项目类别:
Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis
药物诱导史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中致病性 T 细胞的单细胞定义
- 批准号:
9574331 - 财政年份:2018
- 资助金额:
$ 4.3万 - 项目类别:
Understanding and preventing HLA-associated drug reactions
了解和预防 HLA 相关药物反应
- 批准号:
8934766 - 财政年份:
- 资助金额:
$ 4.3万 - 项目类别:
Understanding and preventing HLA-associated drug reactions
了解和预防 HLA 相关药物反应
- 批准号:
9100798 - 财政年份:
- 资助金额:
$ 4.3万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Differences in Hospital Nursing Resources among Black-Serving Hospitals as a Driver of Patient Outcomes Disparities
黑人服务医院之间医院护理资源的差异是患者结果差异的驱动因素
- 批准号:
10633905 - 财政年份:2023
- 资助金额:
$ 4.3万 - 项目类别:
Expanding minority youth access to evidence-based care: A pilot effectiveness trial of a digital mental health intervention
扩大少数族裔青年获得循证护理的机会:数字心理健康干预措施的试点有效性试验
- 批准号:
10647287 - 财政年份:2023
- 资助金额:
$ 4.3万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 4.3万 - 项目类别:
HealthyU-Latinx: A Technology-based Tool for addressing Health Literacy in Latinx Secondary Students and their Families
HealthyU-Latinx:一种基于技术的工具,用于提高拉丁裔中学生及其家庭的健康素养
- 批准号:
10699830 - 财政年份:2023
- 资助金额:
$ 4.3万 - 项目类别:
Consultative Physical Therapy: A Physical Activity and Exercise Implementation Strategy in Parkinson's
咨询物理治疗:帕金森病的身体活动和锻炼实施策略
- 批准号:
10565287 - 财政年份:2023
- 资助金额:
$ 4.3万 - 项目类别: